The Mesial Temporal Lobe Epilepsies

John Libbey - EAN : 9782742007714
,,
Édition papier

EAN : 9782742007714

Paru le : 22 sept. 2011

81,00 € 76,78 €
Disponible
Pour connaître votre prix et commander, identifiez-vous
Notre engagement qualité
  • Benefits Livraison gratuite
    en France sans minimum
    de commande
  • Benefits Manquants maintenus
    en commande
    automatiquement
  • Benefits Un interlocuteur
    unique pour toutes
    vos commandes
  • Benefits Toutes les licences
    numériques du marché
    au tarif éditeur
  • Benefits Assistance téléphonique
    personalisée sur le
    numérique
  • Benefits Service client
    Du Lundi au vendredi
    de 9h à 18h
  • EAN13 : 9782742007714
  • Réf. éditeur : G20771
  • Collection : PROGRESS IN EPI
  • Editeur : John Libbey
  • Date Parution : 22 sept. 2011
  • Disponibilite : Disponible
  • Barème de remise : NS
  • Nombre de pages : 284
  • Format : H:250 mm L:177 mm E:20 mm
  • Poids : 724gr
  • Interdit de retour : Retour interdit
  • Résumé :

    Every year, a Bethel-Cleveland Symposia type colloquium takes place in alternation in Marburg, Cleveland or Lyon.

    This work, which results from the Marburg colloquium, chose to focus on one of the more common forms of partial epilepsies and for which surgery is often the treatment of choice, namely the mesial temporal lobe epilepsies.

    Significant progress has been made over the last few years, particularly in understanding the borderline forms of this type of epilepsy.

    The first part of this work concentrates on the concept of mesial temporal lobe epilepsy and its pathophysiology. The second part addresses the clinical characteristics, in particular the natural evolution of the illness, the different aetiologies and the diagnostic relevance of the ictal semiology. The third part concentrates on the clinical and experimental neurophysiology, while the fourth part addresses imaging techniques. Finally, the last part outlines the current situation of the different therapeutic strategies.

    It is targeted at neurologists, neuropaediatricians, epileptologists, neurosurgeons and all doctors involved in the treatment of focal epilepsies.

Haut de page
Copyright 2026 Cufay. Tous droits réservés.